Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Morf4 family associated protein 1-like 1 (MRFAP1L1) is a protein-coding gene producing a protein that primarily enables protein-protein binding through identical protein binding activity[5][4]. It is an intracellular protein and a paralog of MRFAP1. Functional annotations and research point toward a potential supporting role in neurodegenerative conditions such as Huntington disease-like 1, but the biological and clinical functions of MRFAP1L1 remain incompletely characterized and it is not considered a therapeutic target[5][4]. There is no evidence for receptor, enzyme, or transporter activity, and no reported drug interactions or mechanisms of action. Information about its role as a biomarker or related safety or therapeutic challenges is not available in the current literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Morf4 family associated protein 1-like 1 (MRFAP1L1).